The pilot study was conducted at Emory University Hospital to evaluate the safety, tolerability and preliminary efficacy of Spheramine and included six patients with moderate to advanced Parkinson’s
Researchers reported that the company’s anti-malarial candidates were well tolerated, with no signs of serious toxicity at likely therapeutic dosages suggested by initial in vitro efficacy experiments. The
This dressing is said to be the first 100% medical grade honey product cleared for use on burns and wounds by the FDA. The product is 100% Active
The study is designed to assess the safety and effectiveness of the Traxon System to improve motor function and other functional assessments in acute complete and incomplete spinal
This 28-day proof-of-concept clinical trial was a randomized, double-blind, placebo-controlled trial involving 105 patients with type 2 diabetes with a mean baseline fasting plasma glucose of 187mg/dL and
The European patent has been validated in several European countries including France, Germany, Ireland, Spain, Sweden, Switzerland and the UK. Neuralstem’s patented technology enables, for the first time,
The company’s operating profit tripled to E4.1 million in the first quarter of 2008 compared to the E1.3 million earned in the first quarter of 2007. Net profit
In the clinical study, Orexo compared its new nasal powder spray with a current liquid nasal spray in 13 healthy volunteers. The study showed that the uptake of
Under the agreement, Toyobo Gene Analysis will evaluate Crucell’s Star technology for generating cell lines for the production of recombinant proteins for third-party customers. Financial details of the
The Swiss branch office, located at Bahnhofstrasse 88 in Wettingen, is a subsidiary of Terumo Deutschland based in Eschborn, Germany. The new office will focus will on the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.